Market Place
Market Place
Post Enquiry
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Pharma Deals, Investments and M&As in March 2018
If
the first two months of 2018 saw pharma and biotech firms receive more money
than what
al
India-China border tension may impact billion dollar pharma deal; AZ’s investors worry as key cancer drug fails trial
This week in Phispers, we analyze the
situation at AstraZeneca, where its much anticipated lung canc
GSK’s NiQuitin (nicotine film strips) effectiveness questioned in whistleblower lawsuit
GlaxoSmithKline
(GSK) rang in the New Year with yet another whistleblower lawsuit in the US market.
